アルギニンはRBM39を通じて肝がんにおける代謝を再プログラムする
Dirk Mossmann1, Christoph Müller1, Sujin Park1
1Biozentrum, University of Basel, 4056 Basel, Switzerland.
Cell
|October 7, 2023
まとめ
肝細胞癌 (HCC) のアルギニン濃度の上昇は,細胞代謝の再プログラムによって腫瘍の成長を促します. これは,アルギニンの吸収の増加と,RNA結合モチーフタンパク質39 (RBM39) を含むフィードバックループによって起こります.
科学分野:
- 腫瘍学
- 代謝経路
- 癌の生物学
背景:
- 代謝の再プログラミングは癌の重要な特徴ですが,腫瘍発生性における基礎的なメカニズムと役割は完全に理解されていません.
- 細胞代謝の変化は,がんの発生と進行に大きく寄与する.
研究 の 目的:
- 肝細胞がん (HCC) の発達におけるアルギニン代謝の役割を調査する.
- アルギニンの濃度の変化が腫瘍発生性を促進するメカニズムを解明する.
主な方法:
- ネズミと患者のHCCサンプルにおけるアルギニン濃度の分析
- アルギニンの吸収と変換経路の調査
- アルギニンが全身の代謝再プログラムに与える影響の評価
- アルギニン媒介の代謝制御に関与するRNA結合モチーフタンパク質39 (RBM39) を含む分子標的の特定
主要な成果:
- アルギニンの濃度は,合成が減少したにもかかわらず,ポリアミンへの吸収と変換が減少したため,HCCで上昇しています.
- 高アルギニンのレベルは 糖質,アミノ酸,核酸,脂肪酸経路で 代謝の再プログラムを促進します
- アルギニンはRBM39に結合し,代謝遺伝子発現を調節する.
- RBM39はアスパラジン合成を調節し,アルギニンの吸収を高め,ポジティブなフィードバックループを作成します.
結論:
- アルギニンはHCCにおける重要なシグナル分子の役割を果たし,腫瘍の成長を促すための細胞代謝を再プログラムします.
- アルギニン- RBM39- アスパラジン軸は,HCCにおける腫瘍代謝を維持する新しいメカニズムを表しています.
- アルギニンの代謝をターゲットにすることで,HCCの新たな治療戦略を提案できます.
さらに関連する動画
関連する概念動画
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:19Regulation of Metabolism
9.5K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.5K